ELICIO THERAPEUTICS INC (ELTX) Stock Income Statement
NASDAQ:ELTX - Nasdaq - US28657F1030 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 2.30M | 28.31M | |||
| Cost Of Goods | N/A | N/A | N/A | 0.00 | 430.00K | |||
| Gross Profit | N/A | N/A | N/A | 2.30M | 27.88M | |||
| Operating Expenses | 45.56M | 45.00M | 35.74M | 32.73M | 67.19M | |||
| Research and Development | 33.88M | N/A | 23.85M | 18.10M | 48.70M | |||
| Selling, General, and Administrative Expenses | 11.60M | 11.00M | 11.90M | 14.64M | 18.49M | |||
| Operating Income | -45.56M | -45.00M | -35.74M | -30.43M | -39.31M | |||
| Interest Income/Expense | 239.00K | N/A | -53.00K | 720.00K | -2.19M | |||
| Other Income/Expense | -6.04M | -7.39M | -2.00K | 100.00K | -13.98M | |||
| Non Recurring Items | N/A | 0.00 | 605.00K | -9.19M | 910.00K | |||
| Income Before Taxes | -51.28M | -52.00M | -35.20M | -38.81M | -54.57M | |||
| Income Tax | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Net Income | -51.28M | -52.00M | -35.20M | -38.81M | -54.57M | |||
| EBITDA | -44.39M | -43.82M | -34.58M | -30.25M | -39.22M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.92 | -4.33 | -6.96 | -12.92 | -19.35 | |||
| Non GAAP EPS | -3.92 | -4.20 | N/A | -12.90 | -2.09 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | 100.00% | 98.48% | |||
| Profit Margin | N/A | N/A | N/A | -1687.39% | -192.76% | |||
| Operating Profit Margin | N/A | N/A | N/A | -1323.04% | -138.86% | |||
All data in USD